Goldman Sachs Assumes Arrowhead Pharma (ARWR) at Neutral
(Updated - September 24, 2026 5:33 AM EDT)
Goldman Sachs analyst Andrea Newkirk assumes coverage on Arrowhead Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Goldman Sachs analyst Andrea Newkirk assumes coverage on Arrowhead Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

